NCT01734772 Investigation of Drug-drug Interaction of Dabigatran and Ticagrelor Status COMPLETED Phase PHASE1
NCT01732796 IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1 Status COMPLETED Phase PHASE3
NCT01728324 Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2 Status COMPLETED Phase PHASE3
NCT01726270 An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms Status COMPLETED Phase PHASE2
NCT01721876 Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2) Status COMPLETED Phase PHASE3
NCT01721837 Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment Status COMPLETED Phase N/A
NCT01721525 Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) Status COMPLETED Phase PHASE1
NCT01719003 Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01711853 Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease. Status COMPLETED Phase PHASE1
NCT01708902 Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients Status COMPLETED Phase PHASE3
NCT01707940 Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT01707147 A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase N/A
NCT01704846 Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine Capsules Status COMPLETED Phase PHASE1
NCT01703858 Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608 Status COMPLETED Phase PHASE1
NCT01703845 A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD. Status COMPLETED Phase PHASE1
NCT01703286 Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation) Status COMPLETED Phase PHASE1
NCT01696071 Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication Status COMPLETED Phase PHASE2
NCT01696058 Co-administration of Olodaterol Respimat® and Tiotropium Handihaler® Status COMPLETED Phase PHASE3